Oncological outcomes of the TIME trial in esophageal cancer: is it the era of minimally invasive esophagectomy?
- PMID: 29666808
- PMCID: PMC5890031
- DOI: 10.21037/atm.2017.10.30
Oncological outcomes of the TIME trial in esophageal cancer: is it the era of minimally invasive esophagectomy?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial.Ann Surg. 2017 Aug;266(2):232-236. doi: 10.1097/SLA.0000000000002171. Ann Surg. 2017. PMID: 28187044 Clinical Trial.
References
-
- Mariette C, Meunier B, Pezet D, et al. Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicenter,open-label,randomized phase III controlled trial, the MIRO trial. J Clin Oncol 2015;33:5 10.1200/jco.2015.33.3_suppl.5 - DOI
-
- Sihag S, Kosinski AS, Gaissert HA, et al. Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database. Ann Thorac Surg 2016;101:1281-8; discussion 1288-9. 10.1016/j.athoracsur.2015.09.095 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources